[Effectiveness of praziquantel as an antihelmintic agent in the treatment of bilharziasis].
With the introduction of Praziquantel a highly effective anthelminticum against trematodes and cestodes has become available. After antischistosomal therapy with Praziquantel reduction of parasitic egg excretion occurs rapidly and lasts for at least one year under conditions with a low risk of reinfection. Patients treated with Praziquantel predominantly excrete non-viable eggs and therefore hardly contribute to a further transmission of the disease. Besides this parasitological improvement proteinuria, erythrocyturia, leukocyturia, and previously pathological lesions of the urinary tract as shown ultrasonographically more or less disappear. Praziquantel can therefore at present be considered the drug of choice in the treatment of schistosomiasis.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003223:Congo; D006801:Humans; D010865:Pilot Projects; D011223:Praziquantel / Q000627:therapeutic use*; D012548:Schistosoma haematobium / Q000187:drug effects; D012550:Schistosoma mansoni / Q000187:drug effects; D012553:Schistosomiasis haematobia / Q000188:drug therapy*; D012555:Schistosomiasis mansoni / Q000188:drug therapy*; D013397:Sudan
D011223:Praziquantel
Effektivität von Praziquantel als Anthelmintikum bei der Behandlung von Bilharziose.